326 related articles for article (PubMed ID: 18980631)
1. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
Bizikova P; Papich MG; Olivry T
Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of hydroxyzine and cetirizine following oral administration of hydroxyzine to exercised Thoroughbred horses.
Knych HK; Weiner D; Steinmetz S; Flynn K; McKemie DS
J Vet Pharmacol Ther; 2019 Nov; 42(6):617-623. PubMed ID: 31490561
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine.
Urien S; Tillement JP; Ganem B; Kuch MD
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):499-502. PubMed ID: 10543317
[TBL] [Abstract][Full Text] [Related]
4. Cetirizine in horses: pharmacokinetics and pharmacodynamics following repeated oral administration.
Olsén L; Bondesson U; Broström H; Tjälve H; Ingvast-Larsson C
Vet J; 2008 Aug; 177(2):242-9. PubMed ID: 17581764
[TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacokinetics of H1-receptor antagonists.
Simons FE; Simons KJ; Chung M; Yeh J
Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
7. Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Bondesson U; Broström H; Tjälve H; Larsson P
J Vet Pharmacol Ther; 2007 Jun; 30(3):194-200. PubMed ID: 17472650
[TBL] [Abstract][Full Text] [Related]
8. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
Lefebvre RA; Rosseel MT; Bernheim J
Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
[TBL] [Abstract][Full Text] [Related]
9. Effect of the H2-receptor antagonist cimetidine, on the pharmacokinetics and pharmacodynamics of the H1-receptor antagonists hydroxyzine and cetirizine in rabbits.
Chen X; Simons FE; Simons KJ
Pharm Res; 1994 Feb; 11(2):295-300. PubMed ID: 8165191
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
Spicák V; Dab I; Hulhoven R; Desager JP; Klánová M; de Longueville M; Harvengt C
Clin Pharmacol Ther; 1997 Mar; 61(3):325-30. PubMed ID: 9084458
[TBL] [Abstract][Full Text] [Related]
11. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria.
Simons FE; Sussman GL; Simons KJ
J Allergy Clin Immunol; 1995 Mar; 95(3):685-93. PubMed ID: 7897151
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyzine from topical phospholipid liposomal formulations: evaluation of peripheral antihistaminic activity and systemic absorption in a rabbit model.
Elzainy AA; Gu X; Simons FE; Simons KJ
AAPS PharmSci; 2003 Nov; 5(4):E28. PubMed ID: 15198516
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of clemastine in healthy dogs.
Hansson H; Bergvall K; Bondesson U; Hedeland M; Törneke K
Vet Dermatol; 2004 Jun; 15(3):152-8. PubMed ID: 15214951
[TBL] [Abstract][Full Text] [Related]
14. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
Leroy T; van Neste D
Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cetirizine in healthy cats.
Papich MG; Schooley EK; Reinero CR
Am J Vet Res; 2008 May; 69(5):670-4. PubMed ID: 18447800
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cetirizine in 2- to 6-year-old children.
Pariente-Khayat A; Rey E; Dubois MC; Vauzelle-Kervroedan F; Pons G; D'athis P; Murat II; Pinelli ME; Saint-Maurice C; Olive G
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):340-4. PubMed ID: 7582385
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Van Neste D; Rihoux JP
Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine.
Chen C
Curr Med Chem; 2008; 15(21):2173-91. PubMed ID: 18781943
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Deschamps C; Dubruc C; Mentre F; Rosenzweig P
Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of H1-receptor antagonists in skin and serum.
Simons FE; Murray HE; Simons KJ
J Allergy Clin Immunol; 1995 Mar; 95(3):759-64. PubMed ID: 7897161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
